Rotraut Mössner Selected Research

Acrodermatitis (Gianotti Crosti Syndrome)

10/2021	Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases.
1/2019	Two cases of acrodermatitis continua suppurativa (Hallopeau's disease) treated with IL-17A inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rotraut Mössner Research Topics

Disease

22	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 01/2002
5	Psoriatic Arthritis 05/2019 - 06/2007
5	Melanoma (Melanoma, Malignant) 07/2016 - 09/2002
4	Neoplasms (Cancer) 07/2016 - 09/2002
3	Rheumatoid Arthritis 01/2022 - 09/2008
3	Inflammation (Inflammations) 06/2011 - 06/2004
2	Arthritis (Polyarthritis) 01/2022 - 05/2019
2	Lichen Planus (Lichen Ruber Planus) 01/2022 - 12/2021
2	Pyoderma 01/2022 - 01/2022
2	Eosinophilic Fasciitis 12/2021 - 08/2021
2	Acrodermatitis (Gianotti Crosti Syndrome) 10/2021 - 01/2019
2	Pityriasis Rubra Pilaris 08/2021 - 03/2019
2	Multiple Sclerosis 01/2021 - 04/2016
2	Hypersensitivity (Allergy) 01/2011 - 12/2003
1	Body Weight (Weight, Body) 12/2021
1	Sclerosis 12/2021
1	Localized Scleroderma (Morphea) 12/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 08/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2021
1	Nicolau Syndrome 01/2021
1	Injection Site Reaction 01/2021
1	Skin Diseases (Skin Disease) 03/2019
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2018
1	Ankylosing Spondylitis 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Chronic Mucocutaneous Candidiasis 04/2016
1	Granuloma Annulare 03/2016
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Necrosis 01/2011

Drug/Important Bio-Agent (IBA)

6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2002
5	Infliximab (Remicade)FDA Link 01/2018 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 07/2012 - 09/2002
4	Methotrexate (Mexate)FDA LinkGeneric 08/2021 - 11/2012
4	Etanercept (Enbrel)FDA Link 01/2018 - 09/2008
4	Adalimumab (Humira)FDA Link 01/2018 - 09/2008
3	upadacitinibIBA 01/2022 - 12/2021
3	risankizumabIBA 08/2021 - 10/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 04/2016
3	Tumor Necrosis Factor InhibitorsIBA 01/2009 - 03/2008
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2007 - 09/2002
2	Interleukin-23 (Interleukin 23)IBA 10/2021 - 02/2009
2	Biological ProductsIBA 03/2019 - 01/2015
2	InterleukinsIBA 07/2018 - 01/2002
2	AntibodiesIBA 07/2016 - 09/2008
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2011 - 01/2007
2	Interleukin-16 (Interleukin 16)IBA 01/2011 - 12/2003
2	PPAR gammaIBA 02/2007 - 09/2002
2	PPAR alphaIBA 06/2004 - 09/2002
2	LigandsIBA 06/2004 - 09/2002
2	CytokinesIBA 12/2003 - 01/2002
1	tofacitinibIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021
1	GlucocorticoidsIBA 12/2021
1	Prednisolone (Predate)FDA LinkGeneric 08/2021
1	Rituximab (Mabthera)FDA Link 08/2021
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	guselkumabIBA 11/2020
1	tildrakizumabIBA 11/2020
1	apremilastIBA 05/2019
1	brodalumabIBA 05/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2019
1	Interleukin-17 ReceptorsIBA 05/2019
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2019
1	Lipocalin-2IBA 04/2018
1	AfatinibIBA 02/2018
1	Ustekinumab (CNTO 1275)FDA Link 01/2017
1	Immune Checkpoint InhibitorsIBA 07/2016
1	Monoclonal AntibodiesIBA 07/2016
1	Interferon-betaIBA 04/2016
1	ruxolitinibIBA 04/2016
1	VemurafenibIBA 03/2016
1	Acitretin FDA Link 01/2015
1	FumaratesIBA 01/2015
1	Leflunomide (Arava)FDA LinkGeneric 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2012
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2012
1	1,25-dihydroxyvitamin DIBA 07/2012
1	Genetic Markers (Genetic Marker)IBA 07/2012
1	Vitamin D FDA LinkGeneric 07/2012
1	Vitamin D-Binding ProteinIBA 07/2012
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 07/2012
1	Vitamin D3 24-HydroxylaseIBA 07/2012
1	Anti-Idiotypic AntibodiesIBA 06/2011
1	Formaldehyde (Formol)FDA Link 06/2011
1	ParaffinIBA 06/2011
1	Irritants (Vesicants)IBA 01/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011
1	AcetyltransferasesIBA 01/2011
1	Filaggrin ProteinsIBA 01/2011
1	Superoxide DismutaseIBA 01/2011
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2011
1	HLA-C Antigens (HLA-C)IBA 11/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 07/2009
1	Pharmaceutical PreparationsIBA 09/2008

Therapy/Procedure

9	Therapeutics 12/2021 - 03/2008
1	Aftercare (After-Treatment) 12/2021
1	Intra-Articular Injections 01/2021
1	Subcutaneous Injections 01/2021